123 related articles for article (PubMed ID: 33062723)
1. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma.
Herlea V; Mustafa ES; Iorgescu AC; Pechianu NC; Cretoiu D; Sajin M; Dima SO; Vasilescu C; Stroescu C; Ungureanu C; Dumitrascu T; Brasoveanu V; Ghinescu M; Popescu I
J Immunol Res; 2020; 2020():6148286. PubMed ID: 33062723
[TBL] [Abstract][Full Text] [Related]
2. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
4. Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases.
Reid MD; Muraki T; HooKim K; Memis B; Graham RP; Allende D; Shi J; Schaeffer DF; Singh R; Basturk O; Adsay V
Cancer Cytopathol; 2017 Jul; 125(7):563-575. PubMed ID: 28371566
[TBL] [Abstract][Full Text] [Related]
5. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
7. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
8. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Oct; 33(3):233-9. PubMed ID: 17003643
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.
Sakugawa C; Haruyama Y; Tanaka H; Fukushima T; Kawaguchi M; Kataoka H
BMC Res Notes; 2017 Dec; 10(1):674. PubMed ID: 29202869
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
[TBL] [Abstract][Full Text] [Related]
12. [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
Huo Z; Yang D; Chang XY; Wan JW; Chen J
Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):670-5. PubMed ID: 19094485
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Values of CD38
Zhang M; Yang J; Zhou J; Gao W; Zhang Y; Lin Y; Wang H; Ruan Z; Ni B
Immunol Invest; 2019 Jul; 48(5):466-479. PubMed ID: 30689488
[TBL] [Abstract][Full Text] [Related]
14. Tumour characteristics predictive of survival following resection for ductal adenocarcinoma of the head of pancreas.
Garcea G; Dennison AR; Ong SL; Pattenden CJ; Neal CP; Sutton CD; Mann CD; Berry DP
Eur J Surg Oncol; 2007 Sep; 33(7):892-7. PubMed ID: 17398060
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic ductal adenocarcinomas with multiple large cystic structures: a clinicopathologic and immunohistochemical study of seven cases.
Nitta T; Mitsuhashi T; Hatanaka Y; Hirano S; Matsuno Y
Pancreatology; 2013; 13(4):401-8. PubMed ID: 23890139
[TBL] [Abstract][Full Text] [Related]
16. Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.
Basturk O; Adsay V; Askan G; Dhall D; Zamboni G; Shimizu M; Cymes K; Carneiro F; Balci S; Sigel C; Reid MD; Esposito I; Baldaia H; Allen P; Klöppel G; Klimstra DS
Am J Surg Pathol; 2017 Mar; 41(3):313-325. PubMed ID: 27984235
[TBL] [Abstract][Full Text] [Related]
17. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival.
Coppola D; Lu L; Fruehauf JP; Kyshtoobayeva A; Karl RC; Nicosia SV; Yeatman TJ
Am J Clin Pathol; 1998 Jul; 110(1):16-23. PubMed ID: 9661918
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
